Table 1.
Baseline Characteristics of Patients with TGA Compared to Negative Controls (Migraine and Seizure) and Positive Controls (TIA)a.
| Characteristic | TGA (N = 4,299) | Migraine (N = 170,400) | Seizure (N = 71,087) | TIA (N = 115,105) |
|---|---|---|---|---|
| Age, mean (SD), y | 65 (13) | 38 (12) | 44 (16) | 71 (15) |
| Female | 2,239 (52.1) | 140,120 (82.2) | 32,695 (46.0) | 65,067 (56.5) |
| Race: | ||||
| White | 3,202 (79.4) | 92,705 (58.0) | 37,328 (55.5) | 73,869 (67.8) |
| Black | 94 (2.3) | 16,643 (10.4) | 10,011 (14.9) | 8,113 (7.4) |
| Hispanic | 367 (9.1) | 41,047 (25.7) | 16,016 (23.8) | 18,664 (17.1) |
| Other | 368 (9.1) | 9,315 (5.8) | 3,946 (5.9) | 8,265 (7.6) |
| Payment source: | ||||
| Medicare | 1,752 (40.8) | 13,905 (8.2) | 20,559 (28.9) | 73,924 (64.2) |
| Medicaid | 81 (1.9) | 35,371 (20.8) | 16,571 (23.3) | 7,066 (6.1) |
| Private | 2,184 (50.8) | 89,105 (52.3) | 18,414 (25.9) | 27,581 (24.0) |
| Self-pay | 184 (4.3) | 23,036 (13.5) | 10,934 (15.4) | 3,571 (3.1) |
| Other | 97 (2.3) | 8,929 (5.2) | 4,597 (6.5) | 2,938 (2.6) |
| Hypertension | 1,792 (41.7) | 16,740 (9.8) | 15,424 (21.7) | 72,206 (62.7) |
| Diabetes | 380 (8.8) | 6,243 (3.7) | 7,473 (10.5) | 28,160 (24.5) |
| CHD | 314 (7.3) | 1,227 (0.7) | 3,279 (4.6) | 21,242 (18.5) |
| Atrial fibrillation | 172 (4.0) | 376 (0.2) | 1,599 (2.2) | 12,301 10.7) |
| CHF | 53 (1.2) | 379 (0.2) | 1,581 (2.2) | 7,514 (6.5) |
| CKD | 71 (1.7) | 609 (0.4) | 2,304 (3.2) | 7,004 (6.1) |
| COPD | 73 (1.7) | 1,158 (0.7) | 2,376 (3.3) | 7,534 (6.5) |
| PVD | 56 (1.3) | 181 (0.1) | 664 (0.9) | 4,619 (4.0) |
Abbreviations: CHD, coronary heart disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; SD, standard deviation; TGA, transient global amnesia; TIA, transient ischemic attack.
a
Data are presented as Number (%) of participants unless otherwise specified.